Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 10, Issue 7, Pages 863
Publisher
MDPI AG
Online
2021-07-15
DOI
10.3390/antibiotics10070863
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triclosan tolerance is driven by a conserved mechanism in diverse Pseudomonas species
- (2021) Alexander G. McFarland et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection
- (2021) Rachel Wheatley et al. Nature Communications
- Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
- (2021) Buqing Yi et al. Frontiers in Cellular and Infection Microbiology
- The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies
- (2021) R. Frèdi Langendonk et al. Frontiers in Cellular and Infection Microbiology
- Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients’ Lung
- (2021) Quentin Menetrey et al. Genes
- New Sequence Type ST3449 in Multidrug-Resistant Pseudomonas aeruginosa Isolates from a Cystic Fibrosis Patient
- (2021) Catalina Díaz-Ríos et al. Antibiotics-Basel
- Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia
- (2020) Viola C. Scoffone et al. TRENDS IN MICROBIOLOGY
- The Microbiome in Cystic Fibrosis Pulmonary Disease
- (2020) Alice Françoise et al. Genes
- Computational approaches in efflux pump inhibitors: current status and prospects
- (2020) Ekta Rathi et al. DRUG DISCOVERY TODAY
- Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan‐drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient
- (2020) Andrew B. Gainey et al. PEDIATRIC PULMONOLOGY
- Activity of aztreonam in combination with avibactam, clavulanate, relebactam, and vaborbactam against multidrug resistant Stenotrophomonas maltophilia
- (2020) M Biagi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Achromobacter Infections and Treatment Options
- (2020) Burcu Isler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MexXY RND pump of Pseudomonas aeruginosa PA7 effluxes bi-anionic β-lactams carbenicillin and sulbenicillin when it partners with the outer membrane factor OprA but not with OprM
- (2020) Manu Singh et al. MICROBIOLOGY-SGM
- Antibiotic export by MexB multidrug efflux transporter is allosterically controlled by a MexA-OprM chaperone-like complex
- (2020) Marie Glavier et al. Nature Communications
- Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants
- (2020) Eduarda Silva et al. Frontiers in Cellular and Infection Microbiology
- (R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages
- (2020) Chandra L. Shrestha et al. Scientific Reports
- Comparative Genomic Analyses Reveal Core-Genome-Wide Genes Under Positive Selection and Major Regulatory Hubs in Outlier Strains of Pseudomonas aeruginosa
- (2019) Utkarsh Sood et al. Frontiers in Microbiology
- Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia
- (2019) Vanessa E. Rees et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates
- (2019) Vidya P. Narayanaswamy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bioaccumulation and distribution of cadmium by Burkholderia cepacia GYP1 under oligotrophic condition and mechanism analysis at proteome level
- (2019) Junhui Zhang et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia
- (2019) Paula Blanco et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Overexpression of SmeGH contributes to the acquired MDR of Stenotrophomonas maltophilia
- (2019) Li-Hua Li et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina
- (2019) Mariana Papalia et al. REVISTA ARGENTINA DE MICROBIOLOGIA
- A case report of successful eradication of new isolates of Burkholderia cenocepacia in a child with cystic fibrosis
- (2019) V. Sputael et al. ACTA CLINICA BELGICA
- Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry
- (2019) Elpis Hatziagorou et al. Journal of Cystic Fibrosis
- Achromobacter veterisilvae sp. nov., from a mixed hydrogen-oxidizing bacteria enrichment reactor for microbial protein production
- (2019) Charles Dumolin et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Intracellular Survival and Innate Immune Evasion of Burkholderia cepacia : Improved Understanding of Quorum Sensing‐Controlled Virulence Factors, Biofilm and Inhibitors
- (2019) P. Sankar Ganesh et al. MICROBIOLOGY AND IMMUNOLOGY
- PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection
- (2019) Gabriella Costabile et al. Nanomedicine-Nanotechnology Biology and Medicine
- Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections
- (2018) Nicholas M. Maurice et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Cystic fibrosis transmembrane conductance regulator modulators
- (2018) Elizabeth B. Burgener et al. CURRENT OPINION IN PEDIATRICS
- Antimicrobial activity of six essential oils against Burkholderia cepacia complex: insights into mechanism(s) of action
- (2018) Elena Perrin et al. Future Microbiology
- Anti-biofilm and Anti-Virulence Efficacy of Celastrol Against Stenotrophomonas maltophilia
- (2018) Hye-Rim Kim et al. International Journal of Medical Sciences
- Pseudomonas aeruginosa and Klebsiella pneumoniae Adaptation to Innate Immune Clearance Mechanisms in the Lung
- (2018) Sebastian A. Riquelme et al. Journal of Innate Immunity
- RND transporters in the living world
- (2018) Hiroshi Nikaido RESEARCH IN MICROBIOLOGY
- Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans
- (2018) Frank Fleurbaaij et al. Scientific Reports
- Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens
- (2018) Renee M. Fleeman et al. Frontiers in Microbiology
- Characterization of OXA-258 enzymes and AxyABM efflux pump from Achromobacter ruhlandii
- (2018) Mariana Papalia et al. Journal of Global Antimicrobial Resistance
- Antimicrobial activity of essential oils against multidrug-resistant clinical isolates of the Burkholderia cepacia complex
- (2018) Lakshmi Vasireddy et al. PLoS One
- Target (MexB) and efflux based mechanisms decreasing the effectiveness of the efflux pump inhibitor D13-9001 in P. aeruginosa PAO1: uncovering a new role for MexMN-OprM in efflux of β-lactams and a novel regulatory circuit (MmnRS) controlling MexMN expression
- (2018) Srijan Ranjitkar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
- (2018) Alessandro Cassini et al. LANCET INFECTIOUS DISEASES
- Role of the Multidrug Resistance Efflux Pump MexCD-OprJ in the Pseudomonas aeruginosa Quorum Sensing Response
- (2018) Manuel Alcalde-Rico et al. Frontiers in Microbiology
- Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?
- (2018) Emmanuel Faure et al. Frontiers in Immunology
- Airway microbiota across age and disease spectrum in cystic fibrosis
- (2017) Edith T. Zemanick et al. EUROPEAN RESPIRATORY JOURNAL
- A Pan-Genomic Approach to Understand the Basis of Host Adaptation in Achromobacter
- (2017) Julie Jeukens et al. Genome Biology and Evolution
- Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study
- (2017) B. D. Edwards et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The evolution of lung transplantation for cystic fibrosis: A 2017 update
- (2017) Gregory Snell et al. Journal of Cystic Fibrosis
- Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia
- (2017) So Young Chong et al. Microbial Drug Resistance
- Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease
- (2017) Sushma K. Cribbs et al. Translational Research
- Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis
- (2017) Emma Reece et al. BMC Pulmonary Medicine
- Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation
- (2017) Jennifer Mesureur et al. PLoS Pathogens
- Double-Face Meets the Bacterial World: The Opportunistic Pathogen Stenotrophomonas maltophilia
- (2017) Felipe Lira et al. Frontiers in Microbiology
- Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
- (2017) Viola C. Scoffone et al. Frontiers in Microbiology
- Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models
- (2017) Freija Van den Driessche et al. PLoS One
- Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone
- (2017) Carla López-Causapé et al. Scientific Reports
- Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients
- (2016) Leonie Greipel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa
- (2016) Ya-ping Pan et al. ARCHIVES OF MICROBIOLOGY
- Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
- (2016) M.C. Firmida et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps
- (2016) Hannah Y. Mahmood et al. CURRENT MEDICINAL CHEMISTRY
- Antibiotic resistance in Burkholderia species
- (2016) Katherine A. Rhodes et al. DRUG RESISTANCE UPDATES
- Linocin and OmpW Are Involved in Attachment of the Cystic Fibrosis-Associated Pathogen Burkholderia cepacia Complex to Lung Epithelial Cells and Protect Mice against Infection
- (2016) Siobhán McClean et al. INFECTION AND IMMUNITY
- Contribution of mexAB-oprM and mexXY ( -oprA ) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran
- (2016) Hamid Reza Goli et al. INFECTION GENETICS AND EVOLUTION
- Cystic fibrosis
- (2016) J Stuart Elborn LANCET
- Antibiotic and metal resistance in a ST395 Pseudomonas aeruginosa environmental isolate: A genomics approach
- (2016) Pedro Teixeira et al. MARINE POLLUTION BULLETIN
- Novobiocin binding to NalD induces the expression of the MexAB-OprM pump inPseudomonas aeruginosa
- (2016) Weizhong Chen et al. MOLECULAR MICROBIOLOGY
- Distinguishing between resistance, tolerance and persistence to antibiotic treatment
- (2016) Asher Brauner et al. NATURE REVIEWS MICROBIOLOGY
- Aminoglycoside resistance ofPseudomonas aeruginosain cystic fibrosis results from convergent evolution in themexZgene
- (2016) Michelle H Prickett et al. THORAX
- Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
- (2016) Craig Winstanley et al. TRENDS IN MICROBIOLOGY
- Tripartite assembly of RND multidrug efflux pumps
- (2016) Laetitia Daury et al. Nature Communications
- Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa
- (2016) Yuji Morita et al. Frontiers in Microbiology
- Inactivation of SmeSyRy Two-Component Regulatory System Inversely Regulates the Expression of SmeYZ and SmeDEF Efflux Pumps in Stenotrophomonas maltophilia
- (2016) Chao-Jung Wu et al. PLoS One
- Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
- (2016) Benjamin K. Chan et al. Scientific Reports
- The SmeYZ Efflux Pump of Stenotrophomonas maltophilia Contributes to Drug Resistance, Virulence-Related Characteristics, and Virulence in Mice
- (2015) Yi-Tsung Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intracellular survival of Burkholderia cepacia complex in phagocytic cells
- (2015) Miguel A. Valvano CANADIAN JOURNAL OF MICROBIOLOGY
- The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
- (2015) Xian-Zhi Li et al. CLINICAL MICROBIOLOGY REVIEWS
- Comparative Genomics of Environmental and ClinicalStenotrophomonas maltophiliaStrains with Different Antibiotic Resistance Profiles
- (2015) Benjamin Youenou et al. Genome Biology and Evolution
- Stenotrophomonas, Achromobacter, and Nonmelioid Burkholderia Species: Antimicrobial Resistance and Therapeutic Strategies
- (2015) Anton Peleg et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia
- (2015) Viola C. Scoffone et al. Frontiers in Microbiology
- Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
- (2015) Jürg Dreier et al. Frontiers in Microbiology
- Efflux pump-mediated drug resistance in Burkholderia
- (2015) Nicole L. Podnecky et al. Frontiers in Microbiology
- SmeOP-TolCSmEfflux Pump Contributes to the Multidrug Resistance of Stenotrophomonas maltophilia
- (2014) Cheng-Wen Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Resistance to an Antitubercular 2-Thiopyridine Derivative That Is Also Active against Burkholderia cenocepacia
- (2014) Viola C. Scoffone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Differential Roles of RND Efflux Pumps in Antimicrobial Drug Resistance of Sessile and Planktonic Burkholderia cenocepacia Cells
- (2014) Silvia Buroni et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genomic Insights into Intrinsic and Acquired Drug Resistance Mechanisms in Achromobacter xylosoxidans
- (2014) Yongfei Hu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure of the AcrAB–TolC multidrug efflux pump
- (2014) Dijun Du et al. NATURE
- Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis
- (2014) Rasmus Lykke Marvig et al. NATURE GENETICS
- The Contribution of Antibiotic Resistance Mechanisms in Clinical Burkholderia cepacia Complex Isolates: An Emphasis on Efflux Pump Activity
- (2014) Sung-Pin Tseng et al. PLoS One
- A Linkage between SmeIJK Efflux Pump, Cell Envelope Integrity, and σE-Mediated Envelope Stress Response in Stenotrophomonas maltophilia
- (2014) Yi-Wei Huang et al. PLoS One
- Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
- (2014) César de la Fuente-Núñez et al. PLoS Pathogens
- Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains
- (2014) Maria Trancassini et al. Frontiers in Microbiology
- The problems of antibiotic resistance in cystic fibrosis and solutions
- (2014) Carla López-Causapé et al. Expert Review of Respiratory Medicine
- Comparative genome characterization of Achromobacter members reveals potential genetic determinants facilitating the adaptation to a pathogenic lifestyle
- (2013) Xiangyang Li et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Clinical relevance of the ESKAPE pathogens
- (2013) Jack N Pendleton et al. Expert Review of Anti-Infective Therapy
- A census of RND superfamily proteins in the Burkholderia genus
- (2013) Elena Perrin et al. Future Microbiology
- Structural basis for the inhibition of bacterial multidrug exporters
- (2013) Ryosuke Nakashima et al. NATURE
- Characterization of pbt genes conferring increased Pb2+ and Cd2+ tolerance upon Achromobacter xylosoxidans A8
- (2013) Kateřina Hložková et al. RESEARCH IN MICROBIOLOGY
- Coordinate Hyperproduction of SmeZ and SmeJK Efflux Pumps Extends Drug Resistance in Stenotrophomonas maltophilia
- (2012) Virginia C. Gould et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overcoming Drug Resistance with Alginate Oligosaccharides Able To Potentiate the Action of Selected Antibiotics
- (2012) Saira Khan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Innate Aminoglycoside Resistance of Achromobacter xylosoxidans Is Due to AxyXY-OprZ, an RND-Type Multidrug Efflux Pump
- (2012) Julien Bador et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
- (2012) J. S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: First French data
- (2012) Lucie Amoureux et al. Journal of Cystic Fibrosis
- Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7
- (2012) Y. Morita et al. MICROBIOLOGY-SGM
- First Description of an RND-Type Multidrug Efflux Pump in Achromobacter xylosoxidans, AxyABM
- (2011) Julien Bador et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of Resistance-Nodulation-Division Efflux Pump OperonsmeU1-V-W-U2-Xto Multidrug Resistance of Stenotrophomonas maltophilia
- (2011) Chao-Hsien Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms
- (2011) Tom Coenye et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia
- (2011) Silvia Bazzini et al. PLoS One
- Genomic Expression Analysis Reveals Strategies of Burkholderia cenocepacia to Adapt to Cystic Fibrosis Patients' Airways and Antimicrobial Therapy
- (2011) Nuno P. Mira et al. PLoS One
- Pseudomonas aeruginosa: all roads lead to resistance
- (2011) Elena B.M. Breidenstein et al. TRENDS IN MICROBIOLOGY
- The Binding of Triclosan to SmeT, the Repressor of the Multidrug Efflux Pump SmeDEF, Induces Antibiotic Resistance in Stenotrophomonas maltophilia
- (2011) Alvaro Hernández et al. PLoS Pathogens
- Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations
- (2011) Carla P. Coutinho Frontiers in Cellular and Infection Microbiology
- Pseudomonas aeruginosa Genomic Structure and Diversity
- (2011) Jens Klockgether et al. Frontiers in Microbiology
- Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species
- (2010) Jorge H. Leitão et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Exploring the HME and HAE1 efflux systems in the genus Burkholderia
- (2010) Elena Perrin et al. BMC EVOLUTIONARY BIOLOGY
- Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence
- (2010) P. Drevinek et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Changing Microbial Epidemiology in Cystic Fibrosis
- (2010) J. J. LiPuma CLINICAL MICROBIOLOGY REVIEWS
- Critical biophysical properties in the Pseudomonas aeruginosa efflux gene regulator MexR are targeted by mutations conferring multidrug resistance
- (2010) Cecilia Andrésen et al. PROTEIN SCIENCE
- Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance
- (2009) Silvia Buroni et al. BMC MICROBIOLOGY
- Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
- (2009) P. D. Lister et al. CLINICAL MICROBIOLOGY REVIEWS
- In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria
- (2009) E. Peeters et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Biocide susceptibility of the Burkholderia cepacia complex
- (2009) H. Rose et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of a Naturally Occurring Class D -Lactamase from Achromobacter xylosoxidans
- (2008) Y. Doi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MexCD-OprJ Multidrug Efflux System of Pseudomonas aeruginosa: Involvement in Chlorhexidine Resistance and Induction by Membrane-Damaging Agents Dependent upon the AlgU Stress Response Sigma Factor
- (2008) S. Fraud et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients
- (2008) M. T. G. Holden et al. JOURNAL OF BACTERIOLOGY
- Dynamics of Pseudomonas aeruginosa genome evolution
- (2008) K. Mathee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants
- (2008) Lisa C Crossman et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started